Targeting tumor associated macrophages: The new challenge for nanomedicine-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting tumor associated macrophages: The new challenge for nanomedicine

Published:2017-12 Issue: Volume:34 Page:103-113
ISSN:1044-5323
Container-title:Seminars in Immunology
language:en
Short-container-title:Seminars in Immunology

Author:

Andón Fernando Torres,Digifico Elisabeth,Maeda Akihiro,Erreni Marco,Mantovani Alberto,Alonso María José,Allavena Paola

Funder

Worldwide Cancer Research, UK AND IG

Italian Association for Cancer Research (AIRC)

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference160 articles.

1. Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications;Wicki;J. Control. Release,2015

2. Rational design of cancer nanomedicine: nanoproperty integration and synchronization;Sun;Adv. Mater.,2017

3. Diverse applications of nanomedicine;Pelaz;ACS Nano,2017

4. Cancer nanomedicine: progress, challenges and opportunities;Shi;Nat. Rev. Cancer,2017

5. Combination antitumor therapy with targeted dual-nanomedicines;Dai;Adv. Drug Deliv. Rev.,2017

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of IL-37 in gastrointestinal diseases;Frontiers in Immunology;2024-08-14

2. CRISPR/Cas9 screening: unraveling cancer immunotherapy’s ‘Rosetta Stone’;Trends in Molecular Medicine;2024-08

3. Microfluidic-Derived Docosahexaenoic Acid Liposomes for Targeting Glioblastoma and Its Inflammatory Microenvironment;ACS Applied Materials & Interfaces;2024-07-23

4. Therapeutic Effects of IL-1RA, M2 Cells, and Their Synergistic Impact on a Mouse Model of Rheumatoid Arthritis;Advanced Pharmaceutical Bulletin;2024-03-11

5. Tumor immunotherapy resistance: Revealing the mechanism of PD-1 / PD-L1-mediated tumor immune escape;Biomedicine & Pharmacotherapy;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3